Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.8.0.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Condensed Consolidated Statements Of Operations And Comprehensive Loss        
Revenue
Expenses        
General and administrative 226,606 163,870 729,449 558,120
Sales and marketing 134,737 88,989 435,971 249,591
Professional fees 520,372 400,698 1,182,837 1,272,638
Salaries and office administrative fees 943,510 857,093 2,720,620 1,686,210
Research and development 2,203,985 1,968,490 5,774,004 5,180,466
Total Operating Expenses 4,029,210 3,479,140 10,842,881 8,947,025
Net Operating Loss (4,029,210) (3,479,140) (10,842,881) (8,947,025)
Other Income        
Grants received 136,556 136,556 25,891
Total Other Income 136,556 136,556 25,891
Income tax expense
Net Loss (3,892,654) (3,479,140) (10,706,325) (8,921,134)
Other Comprehensive Income/(Loss)        
Foreign currency translation adjustments (32,399) 15,462 60,415 (33,583)
Total Other Comprehensive Income/(Loss) (32,399) 15,462 60,415 (33,583)
Net Comprehensive Loss $ (3,925,053) $ (3,463,678) $ (10,645,910) $ (8,954,717)
Net Loss per Share - Basic and Diluted $ (0.15) $ (0.15) $ (0.41) $ (0.40)
Weighted Average Shares Outstanding - Basic and Diluted 26,512,195 23,524,982 26,343,101 22,075,538